Since estrogens preferentially induce cyclin D1 to trigger breast cancer proliferation while p21 is transciptionally regulated by ERRα to remove constraints on tumor progression [34], we evaluated the effect of ERRα on the expression of such targets. Here, CDKN1A is linked to breast carcinoma.